Search research articles
Contact Us
Filters
Showing results (121-130 of 140) with videos related to
Page
of 14
Sort By:
Journal of the American Medical Directors Association
|
October 7, 2015
Advanced Age and Medication Prescription: More Years, Less Medications? A Nationwide Report From the Italian Medicines Agency
Graziano Onder, Alessandra Marengoni, Pierluigi Russo, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
September 19, 2017
The Italian compassionate use of sofosbuvir in HCV patients waitlisted for liver transplantation: A national real-life experience
Silvia Martini, Maria Francesca Donato, Chiara Mazzarelli, et al.
International Journal of Molecular Sciences
|
October 27, 2022
Esmethadone (REL-1017) and Other Uncompetitive NMDAR Channel Blockers May Improve Mood Disorders via Modulation of Synaptic Kinase-Mediated Signaling
Stephen M Stahl, Sara De Martin, Andrea Mattarei, et al.
Children (Basel, Switzerland)
|
December 23, 2022
The Use of Psychotropic Medication in Pediatric Oncology for Acute Psychological and Psychiatric Problems: Balancing Risks and Benefits
Johanna M C Blom, Elena Barisone, Marina Bertolotti, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation
|
August 12, 2017
The Italian compassionate use of sofosbuvir observational cohort study for the treatment of recurrent hepatitis C: clinical and virological outcomes
Paola Carrai, Cristina Morelli, Gabriella Cordone, et al.
Pharmaceuticals (Basel, Switzerland)
|
August 26, 2022
Pharmacological Comparative Characterization of REL-1017 (Esmethadone-HCl) and Other NMDAR Channel Blockers in Human Heterodimeric N-Methyl-D-Aspartate Receptors
Ezio Bettini, Stephen M Stahl, Sara De Martin, et al.
European Archives of Psychiatry and Clinical Neuroscience
|
March 8, 2023
Esmethadone-HCl (REL-1017): a promising rapid antidepressant
Maurizio Fava, Stephen M Stahl, Sara De Martin, et al.
International Clinical Psychopharmacology
|
February 27, 2026
Depression severity and efficacy outcomes: post hoc analyses from a phase 3 trial of esmethadone for the adjunctive treatment of major depressive disorder with inadequate response to standard antidepressants
Clotilde Guidetti, George I Papakostas, Steven Stahl, et al.
The Journal of Clinical Psychiatry
|
February 25, 2025
Long-Term Safety and Efficacy of Esmethadone in Patients With Major Depressive Disorder: Findings From a 12-Month Open-Label Study
Maurizio Fava, Luca Pani, Sara De Martin, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
June 27, 2024
Revised criteria for diagnosis and staging of Alzheimer's disease: Alzheimer's Association Workgroup
Clifford R Jack, J Scott Andrews, Thomas G Beach, et al.
Page
of 14
Search research articles
Search
Showing results (121-130 of 140) with videos related to
Sort By:
Page
of 14
Journal of the American Medical Directors Association
|
October 7, 2015
Advanced Age and Medication Prescription: More Years, Less Medications? A Nationwide Report From the Italian Medicines Agency
Graziano Onder, Alessandra Marengoni, Pierluigi Russo, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
September 19, 2017
The Italian compassionate use of sofosbuvir in HCV patients waitlisted for liver transplantation: A national real-life experience
Silvia Martini, Maria Francesca Donato, Chiara Mazzarelli, et al.
International Journal of Molecular Sciences
|
October 27, 2022
Esmethadone (REL-1017) and Other Uncompetitive NMDAR Channel Blockers May Improve Mood Disorders via Modulation of Synaptic Kinase-Mediated Signaling
Stephen M Stahl, Sara De Martin, Andrea Mattarei, et al.
Children (Basel, Switzerland)
|
December 23, 2022
The Use of Psychotropic Medication in Pediatric Oncology for Acute Psychological and Psychiatric Problems: Balancing Risks and Benefits
Johanna M C Blom, Elena Barisone, Marina Bertolotti, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation
|
August 12, 2017
The Italian compassionate use of sofosbuvir observational cohort study for the treatment of recurrent hepatitis C: clinical and virological outcomes
Paola Carrai, Cristina Morelli, Gabriella Cordone, et al.
Pharmaceuticals (Basel, Switzerland)
|
August 26, 2022
Pharmacological Comparative Characterization of REL-1017 (Esmethadone-HCl) and Other NMDAR Channel Blockers in Human Heterodimeric N-Methyl-D-Aspartate Receptors
Ezio Bettini, Stephen M Stahl, Sara De Martin, et al.
European Archives of Psychiatry and Clinical Neuroscience
|
March 8, 2023
Esmethadone-HCl (REL-1017): a promising rapid antidepressant
Maurizio Fava, Stephen M Stahl, Sara De Martin, et al.
International Clinical Psychopharmacology
|
February 27, 2026
Depression severity and efficacy outcomes: post hoc analyses from a phase 3 trial of esmethadone for the adjunctive treatment of major depressive disorder with inadequate response to standard antidepressants
Clotilde Guidetti, George I Papakostas, Steven Stahl, et al.
The Journal of Clinical Psychiatry
|
February 25, 2025
Long-Term Safety and Efficacy of Esmethadone in Patients With Major Depressive Disorder: Findings From a 12-Month Open-Label Study
Maurizio Fava, Luca Pani, Sara De Martin, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
June 27, 2024
Revised criteria for diagnosis and staging of Alzheimer's disease: Alzheimer's Association Workgroup
Clifford R Jack, J Scott Andrews, Thomas G Beach, et al.
Page
of 14